- Home
- PVLA vs SYBT Comparison
PVLA vs SYBT Comparison
Compare PVLA & SYBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PVLA | SYBT |
|---|---|---|
| Founded | 2015 | 1904 |
| Country | United States | United States |
| Employees | 14 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.0B |
| IPO Year | N/A | 2009 |
Fundamental Metrics
Financial Performance| Metric | PVLA | SYBT |
|---|---|---|
| Price | $117.71 | $65.13 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 16 | 4 |
| Target Price | ★ $162.06 | $79.00 |
| AVG Volume (30 Days) | ★ 303.0K | 159.6K |
| Earning Date | 05-14-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 1.99% |
| EPS Growth | N/A | ★ 22.11 |
| EPS | N/A | ★ 4.75 |
| Revenue | N/A | ★ $23,406,000.00 |
| Revenue This Year | N/A | $16.83 |
| Revenue Next Year | N/A | $8.40 |
| P/E Ratio | ★ N/A | $13.56 |
| Revenue Growth | N/A | ★ 3.37 |
| 52 Week Low | $18.23 | $60.75 |
| 52 Week High | $151.18 | $83.83 |
Technical Indicators
Market Signals| Indicator | PVLA | SYBT |
|---|---|---|
| Relative Strength Index (RSI) | 50.44 | 51.19 |
| Support Level | $85.53 | $64.73 |
| Resistance Level | $147.47 | $71.41 |
| Average True Range (ATR) | 7.72 | 1.71 |
| MACD | -2.76 | 0.30 |
| Stochastic Oscillator | 24.11 | 82.26 |
Price Performance
Historical ComparisonAbout PVLA Palvella Therapeutics Inc.
Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.
About SYBT Stock Yards Bancorp Inc.
Stock Yards Bancorp Inc operates as a bank. The bank has two reportable operating segments namely Commercial Banking and Wealth Management and Trust. Its services include loan and deposit services, cash management services, securities brokerage activities, mortgage origination, and others. It generates the majority of its revenue from the Commercial Banking segment.